EN DE

BCM Alliance Berhad, an investment holding company, (0187) Fair Value & Analysis

Healthcare · MY · Market cap 10.2M MYR

BA BCM Alliance Berhad, an investment holding company, 0187 · KLSE
Price0.0100 MYR
Fair Value0.0058 MYR
Upside-42.0%
Quality47/100
Watch BCM Alliance Berhad, an investment holding company, for free, get notified when fair value or trend changes. Watch for free
Mixed Growth
Loss-making · -4.4% net margin
Low debt · generates free cash flow
Mixed vs. peers (4/10)
Narrow moat 13/100
Evidence: Medium Range 0.0053 MYR – 0.0058 MYR Share as image

Fair value as of: Jul 12, 2026

From 10 valuation models · updated 29 days ago

Fair value updated Jul 12, 2026, revised from 0.0110 MYR to 0.0058 MYR (−47.3%) since Jun 26, 2026. Share price +100.0% over the past month.

Below-average quality, and screening another 42% overvalued on our models.

What matters now

  • The price sits above even our optimistic bull case (0.0058 MYR). The favourable scenario is already priced in.
  • Solid but not exceptional quality (47/100) and above fair value, neither a clear bargain nor a standout compounder.
  • The models converge in a tight band (0.0053 MYR to 0.0058 MYR), unusually little disagreement for a valuation.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

0.2430 MYR 0.0050 MYR Fair Value 0.0058 MYR Jan 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 12, 2026.

How to read this chart

60‑month range 0.0050 MYR – 0.2430 MYR · fair‑value band 0.0053 MYR – 0.0058 MYR · the 0.0100 MYR price screens above the 0.0058 MYR fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 12, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

BCM Alliance Berhad, an investment holding company, (0187) currently trades at 0.0100 MYR, while our model-based Fair Value estimate is 0.0058 MYR, implying the stock looks roughly 42.0% overvalued today. The Quality Score stands at 47/100 (below-average quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: medium).

Over the trailing twelve months, BCM Alliance Berhad, an investment holding company, generated revenue of 85.8M MYR at a net margin of -4.4%. Revenue grew 2.8% year over year. It earns a return on equity of -3.5%. Fundamentals as of Jul 12, 2026

Our scenario range runs from 0.0053 MYR (bear case) to 0.0058 MYR (bull case); at 0.0100 MYR, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades near its 52-week high and 100% above its 52-week low, currently above its 200-day average. For context, the median of 10 Healthcare peers we cover trades at 2% fair-value upside, at -42%, 0187 screens richer than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Growth DCF 0.0100 MYR 0.0200 MYR 0.0200 MYR 80
Rev-Margin DCF 0.0100 MYR 0.0200 MYR 0.0200 MYR 74
EV/EBITDA 0.0100 MYR 0.0200 MYR 0.0200 MYR 54
All 10 models by family
DCF Models
FCF DCF 0.0100 MYR 0.0200 MYR 0.0200 MYR 38
5Y Revenue Exit 0.0100 MYR 0.0200 MYR 0.0200 MYR 39
5Y EBITDA Exit 0.0100 MYR 0.0200 MYR 0.0200 MYR 41
10Y Revenue Exit 0.0100 MYR 0.0200 MYR 0.0200 MYR 36
10Y EBITDA Exit 0.0100 MYR 0.0200 MYR 0.0200 MYR 37
Multiples
EV/EBITDA 0.0100 MYR 0.0200 MYR 0.0200 MYR 54
EV/Revenue 0.0100 MYR 0.0200 MYR 0.0200 MYR 43
Asset-Based
NCAV (Graham) 0.0300 MYR 0.0400 MYR 0.0600 MYR 50
Growth DCF
Growth DCF 0.0100 MYR 0.0200 MYR 0.0200 MYR 80
Rev-Margin DCF 0.0100 MYR 0.0200 MYR 0.0200 MYR 74

Widest divergence: Asset-Based (0.0400 MYR) versus DCF Models (0.0200 MYR). Highest evidence: Growth DCF (80).

Notify me when 0187 reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) 85.8M MYR
Revenue growth (YoY) +2.8%
Net margin -4.4%
Return on equity -3.5%
Free cash flow 2.2M MYR FY2025
Operating margin -3.5%

Figures from reported company fundamentals · as of Jul 12, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 47/100

Of which business quality 47 · Market factors (momentum, volatility) 54

Profitability 18
Margins and returns on capital today
Quality Growth 39
Are margins and returns improving?
Cashflow 22
Earnings quality: real cash, not paper profit
Fin. Strength 57
Balance sheet, leverage, solvency risk
Investment 97
Disciplined investing over empire-building
Low Volatility 34
Calm price path (market factor)
Momentum 40
Price trend over the last 3–12 months (market factor)
52W Momentum 100
Distance to the 52-week high (market factor)
Net Issuance 82
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

BCM Alliance Berhad, an investment holding company, distributes commercial laundry equipment, medical devices, and healthcare products in Malaysia and internationally. It operates through seven segments: Investment Holding, Commercial Laundry Equipment, Medical Devices, Healthcare Products, Laundry Services, Food and Beverage, and Others.

Full company description

BCM Alliance Berhad, an investment holding company, distributes commercial laundry equipment, medical devices, and healthcare products in Malaysia and internationally. It operates through seven segments: Investment Holding, Commercial Laundry Equipment, Medical Devices, Healthcare Products, Laundry Services, Food and Beverage, and Others. The company is involved in the supply, installation, testing, and commissioning of vended and on-premise commercial laundry equipment to self-service launderettes, on-premise laundries, and multi-housing laundries; and medical diagnostic imaging equipment and disinfection, sterilization, and surgical room equipment to hospitals, medical centers, physiotherapy and orthopedic centers, and specialists and clinics. It also provides medical equipment, including MRI, CT scans, digital X-rays, mobile C-Arm machines, ICU beds, and patient handling tools, as well as consumables. In addition, the company engages in the supply of clinical devices and healthcare products, such as blood pressure monitors, thermometers, and other clinical products to pharmacies, specialists and clinics, and medical equipment dealers, as well as provides virus attenuation devices and COVID-19 test kits. Further, it sells and distributes fast and moving consumer goods, health food, supplements, and hair and body care products to convenient stores, hypermarkets, groceries marts, and online platforms. Additionally, the company offers on-demand laundry services to hotels liners, wellness centers liners, and other laundries; and launderers, cleaners, dry cleaners, and carpet beaters services, as well as repairs and maintenance. Furthermore, it deals in scientific apparatus instruments appliances and various rescue items for hospitals, laboratories, research institutes, clinics, and other organizations. BCM Alliance Berhad was founded in 1978 and is headquartered in Seri Kembangan, Malaysia.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

BCM Alliance Berhad, an investment holding company, reported revenue of 85.8M MYR in FY2025 versus 75.3M MYR in FY2021, a compound +3.3%/yr. Reported net income was −3.8M MYR in FY2025.

Growth Quality 34/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Latest Revenue (FY 2025)
85.8M MYR
Latest YoY
−14.6%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
−2.4%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+4.7%
Avg. growth/yr (10Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+2.9%
Revenue +3.3%/yr
FY21 75.3M MYR
FY22 92.3M MYR
FY23 94.4M MYR
FY24 101M MYR
FY25 85.8M MYR
Net income
FY21 −1.2M MYR
FY22 −28.7M MYR
FY23 −42.2M MYR
FY24 −9.1M MYR
FY25 −3.8M MYR

0187 screens 42% overvalued. Compare with McKesson Corporation →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "BCM Alliance Berhad, an investment holding company, Fair Value". https://www.fairvalue-calculator.com/stock/0187

Peer Group

Medical Distribution · 81 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 47 · Below median
Fair Value upside −43% · Bottom 25%
Return on assets -1% · Bottom 25%
Net margin (TTM) -4% · Bottom 25%
Operating margin (TTM) -3% · Bottom 25%
Revenue growth 3% · Above median
Debt / equity 0.04× · Lower than median

Valuation Multiples vs Medical Distribution median · lower = cheaper

P/S (TTM) 0.03× · Cheaper than 75% of peers
P/FCF 1.1× · Cheaper than median

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 0 · sector 32
FUTURE 14 · sector 14
PAST 0 · sector 21
HEALTH 98 · sector 97
DIVIDEND 0 · sector 53

VALUE 0: the price sits above our fair-value range.

Insider activity: 40/100

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Medical Distribution stocks, each showing price versus our Fair Value estimate (as of Jul 12, 2026).

Stock Price Fair Value vs Fair Value
McKesson Corporation MCK $805.96 $819.31 +2%
Cencora, Inc COR $303.44 $175.74 -42%
Cardinal Health, Inc CAH $224.94 $141.77 -37%
Henry Schein, Inc HSIC $87.82 $74.67 -15%
Shanghai Pharmaceuticals Holding 601607 ¥16.70 ¥33.96 +103%
Sinopharm Group 1099 HK$16.74 HK$61.33 +266%
Galenica AG GALE CHF 87.05 CHF 61.79 -29%
Guangzhou Baiyunshan Pharmaceutical Holdings 600332 ¥21.50 ¥28.65 +33%
Jointown Pharmaceutical Group 600998 ¥4.99 ¥9.84 +97%
Asker Healthcare Group ASKER kr 79.45 kr 25.69 -68%

Compare BCM Alliance Berhad, an investment holding company, with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is BCM Alliance Berhad, an investment holding company, (0187) overvalued or undervalued?
As of Jul 12, 2026, our model estimates a fair value of 0.0058 MYR versus a price of 0.0100 MYR, about −42% (overvalued).
What is the fair value of 0187?
Our model-based fair value for BCM Alliance Berhad, an investment holding company, is 0.0058 MYR (as of Jul 12, 2026), built from audited fundamentals. The current price is 0.0100 MYR.
What is the quality score of 0187?
BCM Alliance Berhad, an investment holding company, has a Quality Score of 47/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of BCM Alliance Berhad, an investment holding company, (0187)?
BCM Alliance Berhad, an investment holding company, reported trailing-twelve-month revenue of about 85.8M MYR (latest available figure, as of Jul 12, 2026).
What is the net profit margin of 0187?
The net profit margin of BCM Alliance Berhad, an investment holding company, is about -4.4%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track BCM Alliance Berhad, an investment holding company, and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.